Recombinant Human Bone Morphogenetic Protein-2-Induced Radiculitis in Elective Minimally Invasive Transforaminal Lumbar Interbody Fusions A Series Review

被引:84
作者
Mindea, Stefan A. [1 ]
Shih, Patrick [1 ]
Song, John K. [1 ]
机构
[1] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
bone morphogenetic protein; transforaminal lumbar interbody fusion; radiculitis; SPINE FUSION; RHBMP-2; COMPLICATIONS;
D O I
10.1097/BRS.0b013e3181a396a1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Retrospective single center analysis. Objective. The purpose of our study is to quantify the development of a postoperative radiculitis in our minimally invasive transforaminal lumbar interbody fusion patient population. Summary of Background Data. The application of recombinant human Bone Morphogenetic Protein-2 (BMP) in spinal surgery has allowed for greater success in spinal fusions. This has led to the FDA approving its use in anterior lumbar interbody fusion. However, its well-recognized benefits have generated its "off-label" use in the cervical, thoracic, and lumbar spine. Despite its benefits, the adverse effects of its inflammatory properties are just starting to get recognized. Some clear adverse reactions have been documented in the literature in the cervical spine. However, we feel that these inflammatory properties may be present in the lumbar spine as well. Methods. We performed a retrospective chart review of 43 patients who had undergone a minimally invasive transforaminal lumbar interbody fusions. Thirty-five of these patients had BMP and 8 patients did not have BMP. We documented whether there was a preoperative radiculopathy present and whether a radiculopathy was present postoperative. We reviewed radiographic postoperative imaging to establish a structural cause for any radiculopathy. If new or increasing radicular symptoms were present, we attempted to assess the duration of these symptoms. Results. Our analysis, showed that 0 of the 8 patients of the non-BMP group had new radicular symptoms that were not attributed to structural causes. In the BMP group, 4 of the 35 patients (11.4%) had new radicular symptoms without structural etiology. Conclusion. Our analysis suggest that patients undergoing minimally invasive transforaminal lumbar interbody fusions procedures have a higher incidence of developing new radicular symptoms that could be attributed to BMP.
引用
收藏
页码:1480 / 1484
页数:5
相关论文
共 20 条
[1]  
Boden SD, 1998, J SPINAL DISORD, V11, P95
[2]   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[3]   Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device [J].
Burkus, JK ;
Heim, TE ;
Gornet, MF ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2003, 16 (02) :113-122
[4]   Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages [J].
Burkus, JK ;
Gornet, MF ;
Dickman, CA ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2002, 15 (05) :337-349
[5]   Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft [J].
Dimar, John R. ;
Glassman, Steven D. ;
Burkus, Kenneth J. ;
Carreon, Leah Y. .
SPINE, 2006, 31 (22) :2534-2539
[6]   Posterolateral lumbar spine fusion with INFUSE bone graft [J].
Glassman, Steven D. ;
Carreon, Leah ;
Djurasovic, Mladen ;
Campbell, Mitchell J. ;
Puno, Rolando M. ;
Johnson, John R. ;
Dimar, John R. .
SPINE JOURNAL, 2007, 7 (01) :44-49
[7]   Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results [J].
Hackenberg, L ;
Halm, H ;
Bullmann, V ;
Vieth, V ;
Schneider, M ;
Liljenqvist, U .
EUROPEAN SPINE JOURNAL, 2005, 14 (06) :551-558
[8]  
Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
[9]   Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion - A CT analysis [J].
Joseph, Vivek ;
Rampersaud, Yoga Raja .
SPINE, 2007, 32 (25) :2885-2890
[10]   Use of bone morphogenetic protein-2 for adult spinal deformity [J].
Luhmann, SJ ;
Bridwell, KH ;
Cheng, I ;
Imamura, T ;
Lenke, LG ;
Schootman, M .
SPINE, 2005, 30 (17) :S110-S117